IM Cannabis

IMCC · CANADIAN

$1.40−$0.10 (−6.67%)TodayMarket closed · Oct 20, 4:05 PM ET

Prev close $1.50

About IMCC

IM Cannabis Corp. engages in the production and sale of medical cannabis products. The firm's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The firm also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The firm's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.

Employees: 44
Headquarters: TORONTO, Central(HaMerkaz)
Listed: Nov 5, 2019
Sector: Health Care
Industry: Pharmaceuticals
Website: imcannabis.com

Leadership

IM Cannabis executives
Name	Title	Since	Age
Oz Adler	—	2025	39
Oren Shuster	—	2019	—
Uri Birenberg	—	—	—
Richard Balla	—	—	—
Eyal Fisher	—	—	—
Michal Nissimov	—	—	—
Asaf Yitzhaik	—	—	—
Eliyahu Zamir	—	—	55
Moti Marcus	—	—	—
Einat Zakariya	—	—	—

Revenue by product and region

Fiscal year ended Dec 31, 2025: $54.73M total revenue

By region

Germany [Member]$36.35M66.4%
Israel [Member]$18.38M33.6%

Similar companies

Companies in the same industry as IM Cannabis

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.